These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9637512)

  • 1. Structural and functional analysis of J chain-deficient IgM.
    Wiersma EJ; Collins C; Fazel S; Shulman MJ
    J Immunol; 1998 Jun; 160(12):5979-89. PubMed ID: 9637512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activation of human and guinea pig complement by pentameric and hexameric IgM.
    Collins C; Tsui FW; Shulman MJ
    Eur J Immunol; 2002 Jun; 32(6):1802-10. PubMed ID: 12115664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the structure of polymeric IgM.
    Davis AC; Roux KH; Shulman MJ
    Eur J Immunol; 1988 Jul; 18(7):1001-8. PubMed ID: 3136022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of IgM structures involved in J chain incorporation.
    Wiersma EJ; Chen F; Bazin R; Collins C; Painter RH; Lemieux R; Shulman MJ
    J Immunol; 1997 Feb; 158(4):1719-26. PubMed ID: 9029108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hexameric immunoglobulin M in humans: desired or unwanted?
    Petrušić V; Živković I; Stojanović M; Stojićević I; Marinković E; Dimitrijević L
    Med Hypotheses; 2011 Dec; 77(6):959-61. PubMed ID: 21903335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biological effects of IgM hexamer formation.
    Randall TD; King LB; Corley RB
    Eur J Immunol; 1990 Sep; 20(9):1971-9. PubMed ID: 2120070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Problem of J-chain of immunoglobulins].
    Klimovich VB; Samoĭlovich MP; Klimovich BV
    Zh Evol Biokhim Fiziol; 2008; 44(2):131-43. PubMed ID: 18669274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional mu heavy chains.
    Kline GH; Hartwell L; Beck-Engeser GB; Keyna U; Zaharevitz S; Klinman NR; Jäck HM
    J Immunol; 1998 Aug; 161(4):1608-18. PubMed ID: 9712022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay of J chain and disulfide bonding in assembly of polymeric IgM.
    Fazel S; Wiersma EJ; Shulman MJ
    Int Immunol; 1997 Aug; 9(8):1149-58. PubMed ID: 9263012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. J chain synthesis and secretion of hexameric IgM is differentially regulated by lipopolysaccharide and interleukin 5.
    Randall TD; Parkhouse RM; Corley RB
    Proc Natl Acad Sci U S A; 1992 Feb; 89(3):962-6. PubMed ID: 1736312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural requirements for IgM assembly and cytolytic activity. Effects of mutations in the oligosaccharide acceptor site at Asn402.
    Muraoka S; Shulman MJ
    J Immunol; 1989 Jan; 142(2):695-701. PubMed ID: 2911015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into immunoglobulin M.
    Li Y; Wang G; Li N; Wang Y; Zhu Q; Chu H; Wu W; Tan Y; Yu F; Su XD; Gao N; Xiao J
    Science; 2020 Feb; 367(6481):1014-1017. PubMed ID: 32029689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the presence or absence of J chain on expression of recombinant anti-Kell immunoglobulin M.
    Gilmour JE; Pittman S; Nesbitt R; Scott ML
    Transfus Med; 2008 Jun; 18(3):167-74. PubMed ID: 18598279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1q binding properties of monomer and polymer forms of mouse IgM mu-chain variants. Pro544Gly and Pro434Ala.
    Taylor B; Wright JF; Arya S; Isenman DE; Shulman MJ; Painter RH
    J Immunol; 1994 Dec; 153(11):5303-13. PubMed ID: 7963582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. J chain deficiency in human IgM monoclonal antibodies produced by Epstein-Barr virus-transformed B lymphocytes.
    Meng YG; Criss AB; Georgiadis KE
    Eur J Immunol; 1990 Nov; 20(11):2505-8. PubMed ID: 2174785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermolecular disulfide bonding in IgM: effects of replacing cysteine residues in the mu heavy chain.
    Davis AC; Roux KH; Pursey J; Shulman MJ
    EMBO J; 1989 Sep; 8(9):2519-26. PubMed ID: 2511005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Domain-switched mouse IgM/IgG2b hybrids indicate individual roles for C mu 2, C mu 3, and C mu 4 domains in the regulation of the interaction of IgM with complement C1q.
    Chen FH; Arya SK; Rinfret A; Isenman DE; Shulman MJ; Painter RH
    J Immunol; 1997 Oct; 159(7):3354-63. PubMed ID: 9317134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of IgM hexamers by normal and autoimmune B cells: implications for the physiologic role of hexameric IgM.
    Hughey CT; Brewer JW; Colosia AD; Rosse WF; Corley RB
    J Immunol; 1998 Oct; 161(8):4091-7. PubMed ID: 9780180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural requirements for incorporation of J chain into human IgM and IgA.
    Sørensen V; Rasmussen IB; Sundvold V; Michaelsen TE; Sandlie I
    Int Immunol; 2000 Jan; 12(1):19-27. PubMed ID: 10607746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late events in assembly determine the polymeric structure and biological activity of secretory IgM.
    Brewer JW; Corley RB
    Mol Immunol; 1997 Mar; 34(4):323-31. PubMed ID: 9244345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.